CollPlant Biotechnologies Ltd Shareholders' Equity
CollPlant Biotechnologies Ltd (CLGN) had Shareholders' Equity of $6.08 million as of 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-03-26
- 2025-12-31: Stockholders' Equity Attributable to Parent $6.08M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $12.51M.
- 2025-03-31: Stockholders' Equity Attributable to Parent $12.40M.
- 2024-12-31: Stockholders' Equity Attributable to Parent $13.46M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2025-12-31 | $6.08M 20-F · filed 2026-03-26 |
| 2025-06-30 | $12.51M 6-K · filed 2025-08-20 |
| 2025-03-31 | $12.40M 6-K · filed 2025-08-20 |
| 2024-12-31 | $13.46M 20-F · filed 2026-03-26 |
| 2024-06-30 | $20.73M 6-K · filed 2025-08-20 |
| 2024-03-31 | $24.45M 6-K · filed 2025-08-20 |
| 2023-12-31 | $28.34M 20-F · filed 2026-03-26 |
| 2023-06-30 | $36.04M 6-K · filed 2024-08-20 |
| 2023-03-31 | $29.89M 6-K · filed 2024-08-20 |
| 2022-12-31 | $32.28M 20-F · filed 2026-03-26 |
| 2022-06-30 | $39.51M 6-K · filed 2023-08-24 |
| 2022-03-31 | $43.20M 6-K · filed 2023-08-24 |
| 2021-12-31 | $45.12M 20-F · filed 2025-03-26 |
| 2021-06-30 | $49.44M 6-K · filed 2022-08-25 |
| 2021-03-31 | $50.65M 6-K · filed 2022-08-25 |
| 2020-12-31 | $4.48M 20-F · filed 2024-04-04 |
| 2020-06-30 | $5.78M 6-K · filed 2021-08-19 |
| 2020-03-31 | $7.27M 6-K · filed 2021-08-19 |
| 2019-12-31 | $4.09M 20-F · filed 2023-03-29 |
| 2019-06-30 | $764.00K 6-K · filed 2020-08-28 |
| 2019-03-31 | $1.72M 6-K · filed 2020-08-28 |
| 2018-12-31 | $5.42M 20-F · filed 2022-03-24 |
| 2017-12-31 | $5.17M 20-F · filed 2021-03-26 |